These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 16484874)

  • 1. The potential use of antibacterial peptide antibody indices in the diagnosis of rheumatoid arthritis and ankylosing spondylitis.
    Rashid T; Ebringer A; Wilson C; Bansal S; Paimela L; Binder A
    J Clin Rheumatol; 2006 Feb; 12(1):11-6. PubMed ID: 16484874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibodies to Klebsiella, Proteus, and HLA-B27 peptides in Japanese patients with ankylosing spondylitis and rheumatoid arthritis.
    Tani Y; Tiwana H; Hukuda S; Nishioka J; Fielder M; Wilson C; Bansal S; Ebringer A
    J Rheumatol; 1997 Jan; 24(1):109-14. PubMed ID: 9002020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytotoxicity responses to peptide antigens in rheumatoid arthritis and ankylosing spondylitis.
    Wilson C; Rashid T; Tiwana H; Beyan H; Hughes L; Bansal S; Ebringer A; Binder A
    J Rheumatol; 2003 May; 30(5):972-8. PubMed ID: 12734891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibodies to Klebsiella pneumoniae in Dutch patients with ankylosing spondylitis and acute anterior uveitis and to Proteus mirabilis in rheumatoid arthritis.
    Blankenberg-Sprenkels SH; Fielder M; Feltkamp TE; Tiwana H; Wilson C; Ebringer A
    J Rheumatol; 1998 Apr; 25(4):743-7. PubMed ID: 9558179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rheumatoid arthritis patients have elevated antibodies to cross-reactive and non cross-reactive antigens from Proteus microbes.
    Rashid T; Jayakumar KS; Binder A; Ellis S; Cunningham P; Ebringer A
    Clin Exp Rheumatol; 2007; 25(2):259-67. PubMed ID: 17543151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence that Dkk-1 is dysfunctional in ankylosing spondylitis.
    Daoussis D; Liossis SN; Solomou EE; Tsanaktsi A; Bounia K; Karampetsou M; Yiannopoulos G; Andonopoulos AP
    Arthritis Rheum; 2010 Jan; 62(1):150-8. PubMed ID: 20039407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevation in anti-Proteus antibodies in patients with rheumatoid arthritis from Bermuda and England.
    Subair H; Tiwana H; Fielder M; Binder A; Cunningham K; Ebringer A; Wilson C; Hudson MJ
    J Rheumatol; 1995 Oct; 22(10):1825-8. PubMed ID: 8991977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of anti-mutated citrullinated vimentin antibodies in the diagnosis of early rheumatoid arthritis.
    Liu X; Jia R; Zhao J; Li Z
    J Rheumatol; 2009 Jun; 36(6):1136-42. PubMed ID: 19447936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic utility of anti-cyclic citrullinated peptide antibodies for very early rheumatoid arthritis.
    Matsui T; Shimada K; Ozawa N; Hayakawa H; Hagiwara F; Nakayama H; Sugii S; Ozawa Y; Tohma S
    J Rheumatol; 2006 Dec; 33(12):2390-7. PubMed ID: 16924694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The HLA-DRB1 shared epitope is not associated with antibodies against cyclic citrullinated peptide in Chinese patients with rheumatoid arthritis.
    Xue Y; Zhang J; Chen YM; Guan M; Zheng SG; Zou HJ
    Scand J Rheumatol; 2008; 37(3):183-7. PubMed ID: 18465452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The role of anti-cyclic citrullinated peptide (anti-CCP) antibodies in serologic diagnosis and evaluation of disease activity in rheumatoid arthritis].
    Aridoğan BC; Kaya S; Savaş S; Cetin ES; Akkuş S; Demirci M
    Mikrobiyol Bul; 2008 Oct; 42(4):669-74. PubMed ID: 19149089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Shared amino acid sequences between major histocompatibility complex class II glycoproteins, type XI collagen and Proteus mirabilis in rheumatoid arthritis.
    Wilson C; Ebringer A; Ahmadi K; Wrigglesworth J; Tiwana H; Fielder M; Binder A; Ettelaie C; Cunningham P; Joannou C
    Ann Rheum Dis; 1995 Mar; 54(3):216-20. PubMed ID: 7748019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical evaluation of anti-mutated citrullinated vimentin by ELISA in rheumatoid arthritis.
    Soós L; Szekanecz Z; Szabó Z; Fekete A; Zeher M; Horváth IF; Dankó K; Kapitány A; Végvári A; Sipka S; Szegedi G; Lakos G
    J Rheumatol; 2007 Aug; 34(8):1658-63. PubMed ID: 17611988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic impact of contemporary biomarker assays for rheumatoid arthritis.
    Nikolaisen C; Rekvig OP; Nossent HC
    Scand J Rheumatol; 2007; 36(2):97-100. PubMed ID: 17476614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of anti-Proteus antibodies in sera of patients with rheumatoid arthritis.
    Gautam V; Sehgal R; Paramjeet SG; Arora DR
    Indian J Pathol Microbiol; 2003 Jan; 46(1):137-41. PubMed ID: 15027757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measurement characteristics of a new rapid anti-CCP2 test compared to the anti-CCP2 ELISA.
    Snijders GF; Broeder AA; Bevers K; Jeurissen ME; van Eerd JE; van den Hoogen FH
    Scand J Rheumatol; 2008; 37(2):151-4. PubMed ID: 18415774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prolactin and growth hormone responses to hypoglycemia in patients with rheumatoid arthritis and ankylosing spondylitis.
    Rovensky J; Imrich R; Malis F; Zlnay M; Macho L; Koska J; Vigas M
    J Rheumatol; 2004 Dec; 31(12):2418-21. PubMed ID: 15570644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low prevalence of antibodies to glucose-6-phosphate isomerase in patients with rheumatoid arthritis and a spectrum of other chronic autoimmune disorders.
    Matsumoto I; Lee DM; Goldbach-Mansky R; Sumida T; Hitchon CA; Schur PH; Anderson RJ; Coblyn JS; Weinblatt ME; Brenner M; Duclos B; Pasquali JL; El-Gabalawy H; Mathis D; Benoist C
    Arthritis Rheum; 2003 Apr; 48(4):944-54. PubMed ID: 12687536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship of serum TWEAK level to cytokine level, disease activity, and response to anti-TNF treatment in patients with rheumatoid arthritis.
    Park MC; Chung SJ; Park YB; Lee SK
    Scand J Rheumatol; 2008; 37(3):173-8. PubMed ID: 18465450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-CCP2 is an adjunct to, not a surrogate for, rheumatoid factor in the diagnosis of rheumatoid arthritis: diagnostic utility of anti-CCP2 antibodies in Egyptian patients with rheumatoid arthritis.
    Abdel-Nasser AM; Mahmoud MH; El Mansoury TM; Osman AM
    Scand J Rheumatol; 2008; 37(5):329-36. PubMed ID: 18666028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.